Weil Gotshal & Manges has advised Sanofi. Cooley has advised Dynavax Technologies. Sanofi has reached an agreement to acquire Dynavax Technologies Corporation, a publicly traded vaccines...
Sanofi to Acquire Dynavax Technologies in $2.2 Billion Deal
Kura Oncology’s Collaboration with Kyowa Kirin
Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals
Baker McKenzie represented H.Lundbeck A/S (Lundbeck) in the transaction, Cooley represented Longboard Pharmaceuticals and Wilson Sonsini Goodrich & Rosati represented Evercore, Longboard’s financial advisor. H. Lundbeck...
DraftKings’ $750 Million Acquisition of Jackpocket
Sullivan & Cromwell represented DraftKings, while Cooley represented Jackpocket in the transaction. DraftKings, a digital sports entertainment and gaming company, has reached an agreement to acquire...
Roche’s Acquisition of Zion Pharma’s Lead Program Title
Cooley advised Zion Pharma Limited on the deal. Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, announced the acquisition of its...
SCYNEXIS’ License Agreement With GSK for Brexafemme
Cooley advised SCYNEXIS on the deal. SCYNEXIS announced its exclusive license agreement with GSK for Brexafemme. The exclusive license agreement gives GSK rights to commercialize SCYNEXIS’ ibrexafungerp...
Chiesi Farmaceutici’s Acquisition of Amryt Pharma Plc
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
Amgen’s Acquisition of Horizon Therapeutics
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
Vertex’s $320 Million Acquisition of ViaCyte
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
Meta’s Acquisition of Within
Cooley LLP advised Within on the deal. Within, a Los Angeles-based firm responsible for developing immersive virtual reality fitness app Supernatural, announced its agreement to sell to...
Lumentum’s $918 Million Acquisition of NeoPhotonics
Cooley LLP advised NeoPhotonics on the deal. NeoPhotonics, a developer and manufacturer of optoelectronic solutions, announced its agreement to sell to Lumentum for $918 million. The acquisition...